Correspondence 0001493152-26-005613 from AIM ImmunoTech Inc. (AIM)
AIM ImmunoTech Inc.
Date: Feb. 6, 2026 · CIK: 0000946644 · Accession: 0001493152-26-005613
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-292085
Letter
Re: AIM ImmunoTech Inc.
February 6, 2026
VIA EDGAR
Securities and Exchange Commission
F Street, NE
Washington, DC 20549
Registration Statement on Form S-1
(SEC filing No. 333-292085)
Acceleration Request
Requested Date: February 10, 2026
Requested Time: 5:00 P.M. EST
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Securities Act"), AIM ImmunoTech Inc. (the "Company") hereby requests that the above-referenced Registration Statement on Form S-1 (File No. 333-292085) (the "Registration Statement") be declared effective at the "Requested Date" and "Requested Time" set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission (the Commission").
Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Silverman Shin & Schneider PLLC, by calling Richard Feiner, Esq. at (646) 822-1170. We also respectfully request that a copy of the written order from the Commission verifying the effective date and time of the Registration Statement be sent to Mr. Feiner via email at rfeiner@silverfirm.com.
Very truly yours,
AIM IMMUNOTECH INC.
Show Raw Text
CORRESP 1 filename1.htm February 6, 2026 VIA EDGAR Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Re: AIM ImmunoTech Inc. Registration Statement on Form S-1 (SEC filing No. 333-292085) Acceleration Request Requested Date: February 10, 2026 Requested Time: 5:00 P.M. EST Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Securities Act"), AIM ImmunoTech Inc. (the "Company") hereby requests that the above-referenced Registration Statement on Form S-1 (File No. 333-292085) (the "Registration Statement") be declared effective at the "Requested Date" and "Requested Time" set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission (the Commission"). Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Silverman Shin & Schneider PLLC, by calling Richard Feiner, Esq. at (646) 822-1170. We also respectfully request that a copy of the written order from the Commission verifying the effective date and time of the Registration Statement be sent to Mr. Feiner via email at rfeiner@silverfirm.com. Very truly yours, AIM IMMUNOTECH INC. By: / s/ Peter W. Rodino Peter W. Rodino, Chief Operating Officer cc: Richard Feiner, Esq. Corporate Headquarters 2117 SW Highway 484, Ocala FL 34473 t: 352-448-7797 f: 352-480-4620 Human Resources and Administration 604 Main Street, Riverton NJ 08077 t: 352-448-7797 f: 352-480-4620 Operations, Research and Development 671A US-1 South, North Brunswick, NJ 08902 www.aimimmuno.com t: 732-249-3250 f: 732-249-6895